The EMPATHY Pilot Study

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

June 10, 2022

Study Completion Date

July 31, 2022

Conditions
Leukemia, Chronic MyeloidCancer
Interventions
OTHER

EMPATHY Pilot

The goal of this pilot is to develop and pilot a tailored monitoring intervention targeting symptomatic, Patient-reported adverse events (AEs) in chronic myeloid leukemia (CML) Patients undergoing first-line tyrosine kinase inhibitor (TKI) therapy. The tailored monitoring intervention will draw primarily from the PRO-CTCAE Item Library, with additional items drawn from the FACIT and EORTC Item libraries as necessary. After identifying the full set of AEs to be monitored, we will load the Patient assessment and report program into tablets for electronic administration in the busy clinic setting. We will then pilot a six-month intervention aimed to monitor and manage emerging AEs, coupled with assessment of intervention feasibility, Patient acceptability and satisfaction, provider acceptability and clinical management utility, adherence to TKI therapy, and HRQoL. We expect that adherence to therapy, clinical response, and HRQoL will be enhanced by such an intervention.

Trial Locations (16)

30912

Augusta University, Hematology and Oncology, Augusta

60611

Northwestern University, Robert H. Lurie Comprehensive Cancer Center Comprehensive Cancer Center (RHLCCC), Chicago

Unknown

Policlinico Sant'Orsola Malpighi - UOC Ematologia - Azienda Ospedaliero-Universitaria di Bologna, Bologna

"Ospedale A. Businco - Struttura Complessa di Ematologia e CTMO - Azienda Ospedaliera G. Brotzu", Cagliari

Milano Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - UOC Oncoematologia - Padiglione Marcora, Milan

"Azienda Ospedaliera Universitaria - Università degli Studi di Napoli Federico II - UOC Ematologia", Napoli

Azienda Ospedaliera Universitaria Maggiore della Carità di Novara - SCDU Ematologia, Novara

AUSL Reggio Emilia - Arcispedale S. Maria Nuova, IRCSS - SC Ematologia, Reggio Emilia

"Azienda Ospedaliera Universitaria Policlinico Umberto I - Università degli Studi Sapienza - UOC Ematologia", Roma

Ospedale Sant'Eugenio, Roma

Azienda Ospedaliero-Universitario Città della Salute e della Scienza di Torino - Ospedale S. Giovanni Battista Molinette - SC Ematologia, Torino

Ospedale Mauriziano Umberto I - Torino - SCDU Ematologia, Torino

"ASUI di Udine - Presidio Ospedaliero Santa Maria della Misericordia - Clinica Ematologica", Udine

Azienda Ospedaliera Universitario Integrata di Verona, Policlinico G.B. Rossi - UOC Ematologia, Verona

USL 6 - Ospedale San Bortolo - Vicenza, Vicenza

00161

The GIMEMA Foundation (Italian Group for Adult Hematologic Diseases), Rome

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Fondazione GIMEMA

OTHER

collaborator

Augusta University

OTHER

lead

Northwestern University

OTHER

NCT04384848 - The EMPATHY Pilot Study | Biotech Hunter | Biotech Hunter